Becton, Dickinson and Company (BDX)
NYSE · Healthcare
Becton, Dickinson and Company EBITDA 2007–2025
Becton, Dickinson and Company annual/quarterly ebitda history and growth rate from 2007 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Becton, Dickinson and Company ebitda for the quarter ending March 31, 2026 was 656.0 M, a 30.95% decrease year-over-year.
- Becton, Dickinson and Company ebitda for the twelve months ending March 31, 2026 was 3.8 B, a 26.11% decrease year-over-year.
- Becton, Dickinson and Company annual ebitda for 2025 was 5.0 B, a 7.64% increase from 2024.
- Becton, Dickinson and Company annual ebitda for 2024 was 4.7 B, a 6.46% increase from 2023.
- Becton, Dickinson and Company annual ebitda for 2023 was 4.4 B, a 2.48% decrease from 2022.
- Becton, Dickinson and Company annual ebitda for 2022 was 4.5 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Becton, Dickinson and Company EBITDA — FAQ
Becton, Dickinson and Company (BDX) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BDX's ebitda history?
The chart and table above show Becton, Dickinson and Company's ebitda by year and by quarter, including the growth rate.